Unlike the specific case where a lack of CD58 leads to a total loss of CD58-CD2 axis function, in more common scenarios where tumor cells express CD58, the dynamic variation in CD2 expression levels on T cells [35] becomes the primary determinant affecting the axis’s function. This evidence concerns the gene CD2 and neoplasm.